Published in Immunology on October 01, 1979
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest (1985) 2.16
Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. Proc Natl Acad Sci U S A (1982) 1.87
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens. J Exp Med (1983) 1.48
Costimulator deficient antigen presentation by an endothelial cell line induces a nonproliferative T cell activation response without anergy. J Exp Med (1993) 1.30
Implantation site in normal pregnancy. A study with monoclonal antibodies. Am J Pathol (1985) 1.09
Ia antigens in rat kidney, with special reference to their expression in tubular epithelium. J Exp Med (1983) 1.07
Expression of major histocompatibility antigens on pancreatic islet cells. Proc Natl Acad Sci U S A (1981) 1.06
Expression of major histocompatibility complex class II antigens on normal porcine intestinal endothelium. Immunology (1996) 0.96
Adrenocortical cells of the zona reticularis normally express HLA-DR antigenic determinants. Am J Pathol (1987) 0.83
Heterogeneity of HLA-DR+ cells in normal human kidney. Immunohistological and cytochemical characterisation of discrete cell populations. J Clin Pathol (1983) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Studies on fluorescent antibody staining. I. Non-specific fluorescence with fluorescein-coupled sheep anti-rabbit globulins. J Exp Med (1961) 5.53
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med (1978) 4.51
Ia antigen expression on human epidermal Langerhans cells. Nature (1977) 4.05
Epidermal Langerhans cells express Ia antigens. Nature (1977) 3.51
Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med (1978) 3.18
Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93
Structural and serological properties of murine Ia alloantigens. Transplant Rev (1976) 2.35
Cellular distrubtion, purification, and molecular nature of human Ia antigens. Scand J Immunol (1977) 2.04
Nonprecipitating insulin antibodies. J Clin Invest (1958) 2.00
Occurrence of Ia antigens on tissues on non-lymphoid origin. Nature (1978) 1.76
Tissue distribution of I region-associated antigens in the mouse. J Immunol (1974) 1.76
HLA-D associated alloantisera react with molecules similar to Ia antigens. Proc Natl Acad Sci U S A (1977) 1.52
Human Ia-type alloantigens: methods of detection, aspects of chemistry and biology, markers for disease states. Transplant Rev (1976) 1.48
Chemical properties of human Ia antigens. Nature (1977) 1.40
Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay. J Immunol Methods (1973) 1.26
Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology (1977) 1.23
Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules. Immunology (1975) 1.07
Common antigenic structures of HL-A antigens. IV. HL-A common portion fragment isolated from spent culture medium of human lymphoid cell lines. Immunology (1974) 1.03
Common antigenic structures of HL-A antigens. 3. An HL-A common antigenic marker closely associated with HL-A alloantigenic activity and detected by use of rabbit anti-rhesus monkey cell membrane antibodies. Immunology (1974) 0.85
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 9.89
Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature (1986) 9.63
The Zone of Localization of Anti-Mouse-Kidney Serum as Determined by Radioautographs. Science (1949) 8.12
Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer (1981) 5.89
A SIMPLIFIED LYOPHIL APPARATUS. Science (1944) 4.56
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med (1994) 3.89
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst (1998) 3.56
Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A (1997) 3.07
Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93
Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med (1967) 2.47
Number of binding sites of rabbit macroglobulin antibody and its subunits. Immunochemistry (1965) 2.16
Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci U S A (1996) 2.15
Multiple common properties of human beta2-microglobulin and the common portion fragment derived from HL-A antigen molecules. Proc Natl Acad Sci U S A (1973) 2.08
Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02
Subsets of human Ia-like molecules defined by monoclonal antibodies. Mol Immunol (1981) 1.87
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med (1992) 1.76
Preoperative determination of operability in carcinomas of the pancreas and the periampullary region. Ann Surg (1968) 1.75
An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer (1987) 1.72
Serological Reactions with Simple Substances Containing Two or More Haptenic Groups. Proc Natl Acad Sci U S A (1941) 1.60
Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene (1993) 1.60
Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci U S A (1997) 1.59
IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity. Proc Soc Exp Biol Med (1965) 1.55
Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia. Leuk Res (2001) 1.54
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res (1994) 1.54
Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics (1980) 1.48
Immunoglobulin production in human leukemia cell lines. J Immunol (1966) 1.47
Further studies on sperm-immobilizing antibody found in sera of unexplained cases of sterility in women. Am J Obstet Gynecol (1972) 1.45
Glucose-induced insulin secretion and alpha 2-adrenergic receptor subtypes. J Lab Clin Med (1993) 1.39
Immunoadsorbents with high capacity. Immunochemistry (1965) 1.39
The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities. Immunol Rev (1982) 1.39
Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res (1997) 1.38
Statistical approach for the estimation of daily physical activity levels using the probability density function of heart rate. J Biomed Eng (1989) 1.38
Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol Res (1999) 1.38
EB3, a novel member of the EB1 family preferentially expressed in the central nervous system, binds to a CNS-specific APC homologue. Oncogene (2000) 1.37
Isolation of rabbit IgA antihapten antibody and demonstration of skin-sensitizing activity in homologous skin. J Exp Med (1966) 1.37
Immunoglobulin production in synchronized cultures of human hematopoietic cell lines. I. Variation of cellular immunoglobulin level with the generation cycle. J Immunol (1969) 1.36
Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity. Transplantation (1973) 1.35
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene (1992) 1.34
Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice. Am J Surg (1981) 1.34
Nine novel germline mutations of STK11 in ten families with Peutz-Jeghers syndrome. Hum Genet (1998) 1.33
Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986. Cancer (1989) 1.33
Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes (1998) 1.31
Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. Clin Cancer Res (1999) 1.29
Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells. Transplantation (1978) 1.29
HL-A antigens from hematopoietic cell lines: molecular size and electrophoretic mobility. J Immunol (1971) 1.28
Cloning and mapping of SMARCA5 encoding hSNF2H, a novel human homologue of Drosophila ISWI. Cytogenet Cell Genet (1998) 1.28
Change in antibody conformation induced by hapten. Proc Natl Acad Sci U S A (1965) 1.27
Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay. J Immunol Methods (1973) 1.26
Isolation and characterization of free gamma chain of immunoglobulin produced by an established cell line of human myeloma cell origin. I. Gamma chain in culture medium. J Immunol (1969) 1.23
Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology (1977) 1.23
Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver. Hepatology (1997) 1.21
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol (1985) 1.20
Partial amino acid sequence of mouse beta2-microglobulin. Biochem Biophys Res Commun (1976) 1.20
The 11,000-dalton component of mouse H-2. Isolation and identification. Transplantation (1974) 1.19
Detection of receptors for murine B cell stimulatory factor 1 (BSF1): presence of functional receptors on CBA/N splenic B cells. J Immunol (1987) 1.19
The effects of complete modification of amino groups on the antibody activity of antihapten antibodies. Reversible inactivation with maleic anhydride. Biochemistry (1968) 1.19
The component fragments obtained by acid dissociation of papain-solubilized H-2 molecules. J Immunogenet (1976) 1.18
Immunoglobulin M antibodies with ten combining sites. Science (1968) 1.18
An efficient method for isolation of HL-A antigens from hematopoietic cell lines. J Immunol (1971) 1.18
HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer. J Clin Oncol (2000) 1.17
OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc Natl Acad Sci U S A (1998) 1.17
A mouse plasma substance carrying beta2-microglobulin activity and lacking in H-2 alloantigenic activity. J Immunogenet (1976) 1.17
Isolation of a novel gene on 8p21.3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis. Genes Chromosomes Cancer (2000) 1.16
Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity. J Clin Invest (1997) 1.15
The basic structure and the antigenic characteristics of HL-A antigens. Transplant Rev (1974) 1.14
Small bowel perforation caused by metastasis from an extra-abdominal malignancy: report of three cases. Surg Today (2001) 1.13
Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer. Dis Colon Rectum (1990) 1.13
Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood (1994) 1.12
Copper incorporation into ceruloplasmin in rat livers. Biochim Biophys Acta (1995) 1.12
Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody. Eur J Immunol (1981) 1.11
Regional variations in the incidence of end-stage renal failure in Japan. JAMA (2000) 1.11
Absence of a serologically detectable association of murine beta2-microglobulin with the embryonic F9 antigen. Transplantation (1976) 1.11
Immunoglobulin production in cloned sublines of a human lymphocytoid cell line. J Immunol (1969) 1.11
Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int J Cancer (2000) 1.10
VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J Hum Genet (1998) 1.10
Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM. J Immunol (1973) 1.10
Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med (1983) 1.10
The sequence around the active-center tyrosyl residue of bovine pancreatic carboxypeptidase A. Proc Natl Acad Sci U S A (1967) 1.10
Effects of sevoflurane, isoflurane, enflurane, and halothane on left ventricular diastolic performance in dogs. J Cardiothorac Vasc Anesth (1994) 1.09
Amino acid sequence of the light chain derived from a rabbit anti-p-azobenzoate antibody of restricted heterogeneity. Biochem Biophys Res Commun (1973) 1.09
Quantum conversion and image detection by a bacteriorhodopsin-based artificial photoreceptor. Science (1992) 1.08
Analysis of functional domains of Wilson disease protein (ATP7B) in Saccharomyces cerevisiae. FEBS Lett (1998) 1.07